Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 22 Nov 2024
- Closes
- 19 Nov 2026, 23:59 UTC
- Reference
- PAR-25-226
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)”. Submissions close on 19 November 2026, 3 days from today. Quote reference PAR-25-226 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 367 of them currently open. There are 385 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD). Candidate interventions evaluated through this program, which can include small molecules or biologics for example, must engage non-amyloid/non-tau mechanisms and aim to address cognitive and/or neuropsychiatric symptoms in individuals across the spectrum from pre-symptomatic to more severe stages of disease. This NOFO uses the UG3/UH3 phased award mechanism and proposals must include prespecified, go/no-go safety and tolerability milestones that gate the advance from phase 1 to latter stages of clinical development. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
CFDA number(s): 93.242
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 367 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 385 open Healthcare & Pharma tenders in United States. This one closes in 3 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)· closes 1 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- CFAs: Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (United States)· closes 10 Jun
- COMBINED SYNOPSIS/SOLICITATION/ (Brand Name or Equ· closes 1 Dec
- Test Kit, Micro Sample — 1 each, NSN 6515016888714· closes 23 Nov
- Smart Stretchers for the Hudson Valley, Castle Point VA Medical Center.· closes 20 Nov
Explore United States
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка изделий медицинского назначенияГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ СВЕРДЛОВСКОЙ ОБЛАСТИ "ГОРОДСКАЯ БОЛЬНИЦА ГОРОД КАМЕНСК-УРАЛЬСКИЙ" · Russia
- 1. КАРБОПЛАТИН (ОКПД2 21.20 – Препараты лекарственные и материалы, применяемые в медицинских целях), 2 250КРАЕВОЕ ГОСУДАРСТВЕННОЕ КАЗЕННОЕ УЧРЕЖДЕНИЕ "ЦЕНТР ГОСУДАРСТВЕННЫХ ЗАКУПОК ПРИМОРСКОГО КРАЯ" · Russia
- Поставка лекарственного препарата для медицинского применения ФулвестрантКРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "КЛИНИКО-ДИАГНОСТИЧЕСКИЙ ЦЕНТР" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ ХАБАРОВСКОГО КРАЯ · Russia
- Поставка коагулятора в базовой комплектацииКРАЕВОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "ХАБАРОВСКАЯ КРАЕВАЯ СТАНЦИЯ ПО БОРЬБЕ С БОЛЕЗНЯМИ ЖИВОТНЫХ" · Russia
- Поставка медицинских изделий для эндоваскулярной хирургииГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ РЕСПУБЛИКИ КРЫМ "СИМФЕРОПОЛЬСКАЯ ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА №7" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →